Saxagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 43598-619

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Saxagliptin And Metformin Hydrochloride (NDC 43598-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Label for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets 5 mg/500 mg by Dr. Reddy's Laboratories Inc. The film-coated tablets come in a bottle of 30 tablets. The label includes dispensing instructions, warnings not to crush or chew the tablets, storage conditions, and a barcode. The product is made in India and marked Rx only.*

FDA Label Image

Container2 (Container2)

Label for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets 5 mg/1000 mg by Dr. Reddy's Laboratories Inc. The label indicates 30 tablets per package and includes instructions to dispense the Medication Guide and warning to swallow tablets whole without crushing or chewing. It features the NDC 43598-619-30 and states the product is made in India.*

FDA Label Image

Container3 (Container3)

Label for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets, 2.5 mg/1,000 mg strength, film-coated tablets in a bottle of 60 tablets. The label instructs dispensing with the Medication Guide and warns not to crush, cut, or chew the tablets. Distributed by Dr. Reddy's Laboratories Inc.*

FDA Label Image

Figure1 (Figure1)

A line graph showing mean change from baseline in A1C percentage over 24 weeks for Saxagliptin 2.5 mg + Metformin, Saxagliptin 5 mg + Metformin, and Placebo + Metformin groups. The x-axis represents weeks, and the y-axis shows A1C percentage change, with data points and error bars at week 24 LOCF.*

FDA Label Image

Figure2 (Figure2)

Kaplan-Meier cumulative event probability graph displaying event rates over days from randomization for Saxagliptin versus placebo. The chart shows similar probabilities of around 7.4% events for both groups, with accompanying risk numbers at multiple time points. The inset includes hazard ratio statistics comparing Saxagliptin to placebo.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of Saxagliptin showing its molecular formula (C18H25N3O2·H2O) and molecular weight (333.43). The diagram illustrates the arrangement of atoms and bonds within the Saxagliptin molecule.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of Saxagliptin Hydrochloride, showing atom connectivity for the compound with molecular formula C4H11N5·HCl and molecular weight 165.62.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.